ANTOINETTE MARIA: Open Payments
NPI 1801267976 · ELMIRA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,467 in 217 payments from 13 companies in 2025. Trend: 2023 $3,187 · 2024 $3,366 · 2025 $3,467
Food & beverage: $3,467
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 36 | $676 |
| ABBVIE INC. | 27 | $618 |
| Teva Pharmaceuticals USA, Inc. | 52 | $532 |
| Neurocrine BioSciences, Inc. | 33 | $468 |
| Alkermes, Inc. | 12 | $246 |
| Supernus Pharmaceuticals, Inc. | 18 | $196 |
| E.R. Squibb & Sons, L.L.C. | 12 | $193 |
| Janssen Pharmaceuticals, Inc | 8 | $158 |
| Otsuka America Pharmaceutical, Inc. | 6 | $138 |
| Lundbeck LLC | 5 | $102 |
Products named: CAPLYTA, VRAYLAR, INGREZZA, UZEDY, ARISTADA, REXULTI, Qelbree, COBENFY.
Industry payments across NY — which companies pay providers there.
